Baker Brothers Advisors - NEUROCRINE BIOSCIENCES INC ownership

NEUROCRINE BIOSCIENCES INC's ticker is and the CUSIP is 64125CAD1. A total of 32 filers reported holding NEUROCRINE BIOSCIENCES INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Baker Brothers Advisors ownership history of NEUROCRINE BIOSCIENCES INC
ValueSharesWeighting
Q3 2020$42,342,000
-17.2%
30,770,0000.0%0.17%
-25.2%
Q2 2020$51,144,000
+30.1%
30,770,0000.0%0.23%
-6.6%
Q1 2020$39,321,000
-16.6%
30,770,0000.0%0.24%
-3.6%
Q4 2019$47,123,000
+11.9%
30,770,0000.0%0.25%
-12.2%
Q3 2019$42,113,000
+3.9%
30,770,0000.0%0.29%
+3.6%
Q2 2019$40,541,000
-43.7%
30,770,000
-42.2%
0.28%
-40.1%
Q1 2019$71,994,000
+13.5%
53,270,0000.0%0.46%
-11.2%
Q4 2018$63,434,000
+271.8%
53,270,000
+432.7%
0.52%
+363.4%
Q3 2018$17,062,000
+17.9%
10,000,0000.0%0.11%
+2.8%
Q2 2018$14,466,00010,000,0000.11%
Other shareholders
NEUROCRINE BIOSCIENCES INC shareholders Q3 2023
NameSharesValueWeighting ↓
CSS LLC/IL 15,659,000$23,207,6871.52%
SONA ASSET MANAGEMENT (US) LLC 17,500,000$26,317,9521.09%
TENOR CAPITAL MANAGEMENT Co., L.P. 26,765,000$40,113,0990.86%
Warberg Asset Management LLC 1,271,000$1,885,8460.38%
SSI INVESTMENT MANAGEMENT LLC 2,296,000$3,406,1160.28%
Paloma Partners Management Co 3,125,000$4,694,5900.16%
FRANKLIN RESOURCES INC 54,750,000$81,769,1250.04%
Rock Springs Capital Management LP 1,000,000$1,497,9500.04%
LORD, ABBETT & CO. LLC 4,666,000$6,9220.03%
D. E. Shaw & Co., Inc. 14,351,000$21,373,1970.02%
View complete list of NEUROCRINE BIOSCIENCES INC shareholders